Examkin

Soru

Zorluk: ZorPharmacologic Interventions

A 67-year-old man is admitted to the hospital with a 3-day history of productive cough, fever, shortness of breath, and right-sided pleuritic chest pain. His past medical history is significant for symptomatic atrial fibrillation, heart failure with preserved ejection fraction, and type 2 diabetes mellitus. His current medications include sotalol, apixaban, metformin, and empagliflozin. He has no known drug allergies.

Vital signs are:
Temperature: 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F})
Blood pressure: 118/74 mmHg118/74 \text{ mmHg}
Pulse: 88/min88/\text{min}
Respirations: 28/min28/\text{min}
Oxygen saturation: 91%91\% on room air

Physical examination reveals bronchial breath sounds and crackles over the right lower lung field.

Laboratory results are as follows:
Leukocyte count: 14,500/mm314,500/\text{mm}^3 (85%85\% neutrophils)
Blood urea nitrogen: 28 mg/dL28 \text{ mg/dL}
Creatinine: 1.2 mg/dL1.2 \text{ mg/dL}

Chest radiography demonstrates a dense consolidation in the right lower lobe. An electrocardiogram shows normal sinus rhythm with a heart rate of 88/min88/\text{min} and a QTc interval of 490 ms490 \text{ ms} (normal: ≤440 ms\leq 440 \text{ ms} in men).

The patient is diagnosed with community-acquired pneumonia. Which of the following is the most appropriate empiric pharmacologic intervention for this patient?

  1. A
    Intravenous ceftriaxone and oral azithromycin
  2. B
    Intravenous levofloxacin
  3. Intravenous ceftriaxone and oral doxycyclineCevap
  4. D
    Intravenous piperacillin-tazobactam and intravenous vancomycin
  5. E
    Intravenous ceftriaxone and oral clarithromycin

Cevap

Intravenous ceftriaxone and oral doxycycline
The correct intervention is intravenous ceftriaxone and oral doxycycline. This patient requires inpatient admission for community-acquired pneumonia (CAP). Standard empiric therapy for non-severe inpatient CAP consists of a beta-lactam (e.g., ceftriaxone) combined with a macrolide (e.g., azithromycin), or respiratory fluoroquinolone (e.g., levofloxacin) monotherapy. However, this patient has a significantly prolonged baseline QTc interval (490 ms) and is currently taking sotalol, a Class III antiarrhythmic known to delay ventricular repolarization. Both macrolides and fluoroquinolones can further prolong the QTc interval, placing this patient at an unacceptably high risk for life-threatening arrhythmias, specifically Torsades de Pointes. Doxycycline provides excellent atypical coverage for CAP (e.g., Mycoplasma, Legionella) and does not affect the QTc interval. Therefore, substituting the macrolide with doxycycline is the safest and most appropriate guideline-concordant modification.

Adım Adım Çözüm

1
Assess the clinical presentation and diagnostic findings to confirm the diagnosis.
The patient has community-acquired pneumonia (CAP) requiring inpatient admission based on symptoms, imaging, and elevated CURB-65 criteria (age > 65, BUN > 19).
Establishing the correct diagnosis and appropriate level of care determines the initial empiric antibiotic pathways.
2
Review the patient's baseline diagnostic testing and current medication list for potential contraindications.
The electrocardiogram shows a prolonged QTc interval of 490 ms, and the medication list includes sotalol (a Class III antiarrhythmic known to prolong QTc) and apixaban (a CYP3A4/P-gp substrate).
Identifying baseline risk factors is critical before prescribing new pharmacologic interventions, particularly antibiotics with known cardiac or metabolic interactions.
3
Evaluate standard empiric antibiotic regimens for inpatient CAP against the patient's specific safety profile.
Standard therapies (beta-lactam plus macrolide, or respiratory fluoroquinolone) are unsafe because both macrolides (azithromycin, clarithromycin) and fluoroquinolones (levofloxacin) further prolong the QTc interval, risking Torsades de Pointes.
Applying safety constraints eliminates the most commonly prescribed first-line options for this specific patient.
4
Select the optimal alternative guideline-concordant regimen that avoids identified risks.
A beta-lactam (ceftriaxone) combined with doxycycline is chosen.
Doxycycline provides the necessary coverage for atypical pathogens in CAP without affecting ventricular repolarization.

Anahtar Kavram

Pharmacologic management of community-acquired pneumonia in patients with prolonged QTc intervals or taking QTc-prolonging medications.
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru